Why do dialysis patients die

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Dialysis patients face elevated mortality rates primarily due to cardiovascular complications, infections, and dialysis withdrawal. According to the United States Renal Data System, the annual mortality rate for dialysis patients is approximately 15-20%, with cardiovascular disease accounting for about 40% of deaths. Infections, particularly sepsis, contribute to 10-15% of fatalities, often linked to vascular access complications. Additionally, about 20-25% of deaths result from patients choosing to discontinue dialysis, typically due to poor quality of life or advanced age.

Key Facts

Overview

Dialysis serves as a life-sustaining treatment for patients with end-stage renal disease (ESRD), replacing kidney function by filtering waste and excess fluids from the blood. The first successful hemodialysis treatment was performed by Dr. Willem Kolff in 1943 using a primitive rotating drum device. Today, approximately 2 million people worldwide receive dialysis treatment, with over 550,000 patients in the United States alone according to 2022 data from the United States Renal Data System. The development of the arteriovenous fistula by Dr. Belding Scribner in 1960 revolutionized dialysis access, while Medicare's 1972 ESRD program expansion made treatment widely accessible in the U.S. Despite technological advances, dialysis patients face significantly higher mortality rates compared to the general population, with survival influenced by age, comorbidities, and treatment adherence.

How It Works

Dialysis mortality results from complex interactions between treatment limitations and underlying health conditions. The cardiovascular burden is particularly significant: dialysis causes rapid fluid and electrolyte shifts that strain the heart, while uremia promotes vascular calcification and inflammation. Vascular access complications represent another major mechanism - infections at catheter sites can progress to sepsis, while fistula/graft issues increase thrombosis risk. The dialysis procedure itself creates vulnerabilities: blood contact with artificial surfaces activates inflammatory pathways, and treatment removes both toxins and beneficial substances like amino acids. Furthermore, dialysis inadequately replaces all kidney functions, failing to regulate hormones like erythropoietin (causing anemia) and vitamin D (contributing to bone disease). These physiological stresses combine with high rates of diabetes and hypertension in ESRD patients to create multiple pathways to mortality.

Why It Matters

Understanding dialysis mortality has profound implications for healthcare systems and patient care. With global dialysis costs exceeding $100 billion annually, improving outcomes represents both a humanitarian imperative and economic necessity. High mortality rates underscore the urgent need for better kidney disease prevention, earlier intervention strategies, and transplantation access improvements. For patients and families, this knowledge informs difficult decisions about treatment options and end-of-life planning. Clinically, these mortality patterns drive quality improvement initiatives focusing on infection control, cardiovascular management, and palliative care integration. The stark survival statistics - with 5-year rates around 35-40% - highlight dialysis as a treatment that sustains life but doesn't fully restore health, emphasizing the importance of comprehensive care approaches addressing both physical and psychosocial needs.

Sources

  1. HemodialysisCC-BY-SA-4.0
  2. Kidney FailureCC-BY-SA-4.0
  3. United States Renal Data System 2022 Annual Data ReportPublic Domain

Missing an answer?

Suggest a question and we'll generate an answer for it.